4.3 Article

Prognostic significance of CD44 in human colon cancer and gastric cancer: Evidence from bioinformatic analyses

期刊

ONCOTARGET
卷 7, 期 29, 页码 45538-45546

出版社

IMPACT JOURNALS LLC
DOI: 10.18632/oncotarget.9998

关键词

CD44; the cancer genome atlas; gastric cancer; colon cancer; bioinformatic analyses

资金

  1. National Natural Scientific Foundation of China [81572777, 81502558]
  2. Talents Introduction Projects of Liaoning Medical University

向作者/读者索取更多资源

CD44 is a well-recognized stem cell biomarker expressed in colon and gastric cancer. In order to identify whether CD44 mRNA could be used as a prognostic marker in colon and gastric cancer, bioinformatic analyses were used in this study. cBioPortal analysis and COSMIC analysis were used to explore the CD44 mutation. CD44 mRNA levels were evaluated by using SAGE Genie tools and Oncomine analysis. Kaplan-Meier Plotter was performed to identify the prognostic roles of CD44 mRNA in these two cancers. In this study, first, we found that low alteration frequency of CD44 mRNA in colon and gastric cancer. Second, the high CD44 mRNA level was found in colon and gastric cancer, and it correlated with a benign survival rate in gastric cancer. Third, CD4 and CD74 may be used as markers to predict the prognosis of colon and gastric cancer. However, the deep mechanism(s) of these results remains unclear, further studies have to be performed in the future.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.3
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据